VIR BIOTECHNOLOGY, I

VIR
Delayed Quote. Delayed  - 07/30 04:00:00 pm
35.65USD -2.03%
Valuation
Fiscal Period: December 2020 2021
Capitalization1 3 4114 636
Entreprise Value (EV)1 2 6754 272
P/E ratio -10,7x-13,5x
Yield --
Capitalization / Revenue 44,7x16,3x
EV / Revenue 35,0x15,1x
EV / EBITDA -9,17x-17,4x
Price to Book --
Nbr of stocks (in thousands) 127 389130 040
Reference price (USD) 26,835,7
Announcement Date 02/25/2021-
Previous period Next period
1 USD in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2020 2021
Net sales1 76,4284
EBITDA1 -292-246
Operating profit (EBIT)1 -297-294
Operating Margin -389%-104%
Pre-Tax Profit (EBT)1 -299-324
Net income1 -299-331
Net margin -391%-117%
EPS2 -2,51-2,65
Dividend per Share2 --
Announcement Date 02/25/2021-
Previous period Next period
1 USD in Million
2 USD
Finances - Leverage
Fiscal Period: December 2020 2021
Net Debt1 --
Net Cash position1 737364
Leverage (Debt / EBITDA) 2,53x1,48x
Free Cash Flow1 -197-236
ROE (Net Profit / Equities) -52,4%-65,7%
Shareholders' equity1 570504
ROA (Net Profit / Asset) -41,7%-48,8%
Assets1 715678
Book Value Per Share --
Cash Flow per Share2 -1,60-0,07
Capex1 6,556,10
Capex / Sales 8,58%2,15%
Announcement Date 02/25/2021-
Previous period Next period
1 USD in Million
2 USD
Financial Ratios
Size 2021e 2022e
Capitalization 4 636 M $ -
Entreprise Value (EV) 4 272 M $ 3 941 M $
Valuation 2021e 2022e
P/E ratio (Price / EPS) -13,5x -20,7x
Capitalization / Revenue 16,3x 9,96x
EV / Revenue 15,1x 9,18x
EV / EBITDA -17,4x -126x
Yield (DPS / Price) - -
Price to book (Price / BVPS) - -
Profitability 2021e 2022e
Operating Margin (EBIT / Sales) -104% -40,3%
Operating Leverage (Delta EBIT / Delta Sales) 0,00x 0,57x
Net Margin (Net Profit / Revenue) -117% -48,6%
ROA (Net Profit / Asset) -48,8% -38,5%
ROE (Net Profit / Equities) -65,7% -51,5%
Rate of Dividend - -
Balance Sheet Analysis 2021e 2022e
CAPEX / Sales   2,15% 1,53%
Cash Flow / Sales -3,22% -1,16%
Capital Intensity (Assets / Sales) 2,39x 1,26x
Financial Leverage (Net Debt / EBITDA) - -
EPS & Dividend